Dextran sulfate specifically interacts with the human LFA-1 molecule (leucocyte function associated antigen-1)

Area of Science:

• Immunology
• Virology
• Biochemistry

Background:

• The LFA-1 molecule is implicated in HIV-1 induced syncytia formation.
• Dextran sulfate (DxS) is known to inhibit syncytia formation.
• Understanding the mechanism of DxS action on LFA-1 is crucial for HIV-1 research.

Purpose of the Study:

• To investigate the effect of dextran sulfate (DxS) on LFA-1 molecule expression in human lymphocytes.
• To identify the specific interactions between DxS and LFA-1 epitopes.
• To elucidate the role of DxS in modulating LFA-1 expression relevant to HIV-1 pathogenesis.

Main Methods:

• Flow cytometry was used to analyze LFA-1 expression on human lymphocytes.
• A panel of monoclonal antibodies (Mabs) was employed to identify LFA-1 epitopes.
• Incubation experiments at varying temperatures (4°C and 37°C) assessed the kinetics and specificity of DxS interaction with LFA-1 and other cell surface molecules (CD4, CD8, CD3, CD2, CD45R).

Main Results:

• Dextran sulfate (DxS) was found to interact with specific epitopes on the alpha chain of the LFA-1 molecule, leading to decreased LFA-1 expression.
• This inhibition occurred within 1-3 hours at both 4°C and 37°C, with LFA-1 reappearing upon removal of DxS.
• DxS affected LFA-1 expression similarly across different cell subsets and did not inhibit other lymphocyte surface markers at 4°C, but decreased CD45R and CD4 expression at specific temperatures.

Conclusions:

• Dextran sulfate (DxS) exerts an inhibitory effect on LFA-1 expression through steric hindrance of specific LFA-1 determinants.
• This modulation of LFA-1 expression by DxS likely contributes to its observed inhibitory effect on HIV-1 induced syncytium formation.
• The findings provide insights into the molecular mechanisms underlying DxS's antiviral properties.